<SEC-DOCUMENT>0001571049-16-011634.txt : 20160210
<SEC-HEADER>0001571049-16-011634.hdr.sgml : 20160210
<ACCEPTANCE-DATETIME>20160210161522
ACCESSION NUMBER:		0001571049-16-011634
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20160210
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160210
DATE AS OF CHANGE:		20160210

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			APPLIED DNA SCIENCES INC
		CENTRAL INDEX KEY:			0000744452
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
		IRS NUMBER:				592262718
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36745
		FILM NUMBER:		161405909

	BUSINESS ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790
		BUSINESS PHONE:		631-240-8800

	MAIL ADDRESS:	
		STREET 1:		50 HEALTH SCIENCES DRIVE
		CITY:			STONY BROOK
		STATE:			NY
		ZIP:			11790

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PROHEALTH MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20010504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DCC ACQUISITION CORP
		DATE OF NAME CHANGE:	19990211

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DATALINK CAPITAL CORP/TX/
		DATE OF NAME CHANGE:	19980306
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>t1600054_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>WASHINGTON, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>PURSUANT TO SECTION 13 OR 15(d) OF THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Date of Report (Date of earliest event reported):
February 10, 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>Applied
DNA Sciences, Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Exact name of registrant as specified in its
charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Delaware</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">(State or other jurisdiction<BR>
        of incorporation)</P></TD>
    <TD STYLE="text-align: center; width: 34%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>001-36745</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Commission File Number)</P></TD>
    <TD STYLE="text-align: center; width: 33%">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>59-2262718</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">(IRS Employer</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Identification No.)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>50 Health Sciences Drive</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Stony Brook, New York 11790</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Address of principal executive offices; zip
code)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">Registrant&rsquo;s telephone number, including
area code:<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>631-240-8800</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>N/A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">(Former name or former address, if changed since
last report)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.3in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.3in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.3in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.3in; text-align: left"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify">Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 2.02&nbsp;&nbsp;Results of Operations and Financial Condition.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">On February 10, 2016, Applied DNA Sciences, Inc. (&ldquo;Applied
DNA Sciences&rdquo; or the &ldquo;Company&rdquo;) issued a press release announcing its results of operations for the fiscal quarter
ended December 31, 2015. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The information furnished pursuant to this Item 2.02, including
Exhibit 99.1, shall not be deemed &ldquo;filed&rdquo; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended
(the &ldquo;Exchange Act&rdquo;), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated
by reference into any filing of the Company under the Securities Act of 1933 or the Exchange Act, except as shall be expressly
set forth by specific reference in such filing.<B> </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Item 9.01.&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">(<I>d) Exhibits</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.5in; text-align: left">99.1</TD><TD STYLE="text-align: justify">Press Release of Applied DNA Sciences, Inc. dated February
10, 2016 regarding results of operations for the fiscal quarter ended December 31, 2015.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Date: February 10, 2016</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">APPLIED DNA SCIENCES, INC.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 43%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt">/s/ James A. Hayward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">James A. Hayward</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>EXHIBIT INDEX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; font-weight: bold; width: 11%"><FONT STYLE="font-size: 10pt"><B>Exhibit No.</B></FONT></TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; font-weight: bold; width: 87%"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">99.1</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Press Release issued by Applied DNA Sciences, Inc. dated February 10, 2016 regarding results of operations for the fiscal quarter ended December 31, 2015.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>t1600054_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="text-align: left; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><IMG SRC="logo1.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>Applied DNA Sciences Reports<BR>
Fiscal First Quarter 2016 Financial Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><I>Company To Hold Conference Call and Webcast
Today at 4:30 PM Eastern Time</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; text-align: center; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>STONY
BROOK, N.Y., February 10, 2016.</B>Applied DNA Sciences, Inc. (NASDAQ: APDN) (&ldquo;Applied DNA&rdquo;) (Twitter: @APDN), a provider
of DNA-based supply chain, anti-counterfeiting and anti-theft technology, product genotyping and product authentication solutions,
announced financial results for the fiscal 2016 first quarter ended December 31, 2015</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&ldquo;Our fiscal first quarter performance
reflects continued penetration of near-term business verticals beyond textiles, our most mature vertical,&rdquo; stated Dr. James
A. Hayward, President and Chief Executive Officer of Applied DNA Sciences. &ldquo;We are pleased to report revenue growth on a
year-over-year basis, which was driven by orders from our Diagnostics and Asset Marking verticals and two government contract awards.
As expected, seasonality of the cotton ginning season caused revenue to dip from the fiscal 2015 fourth quarter&quot;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Dr. Hayward continued, &ldquo;Our DNA-based
solutions are applicable to multiple verticals; our momentum was sustained this quarter toward commercial deployment as part of
our ongoing strategy to diversify our revenue base as our DNA-based security solutions for supply chains continued to gain traction.
The textiles market affords us substantial opportunity and we are expanding our penetration of this market with additional brands
and retailers that should translate to greater diversity of textile revenue than we achieved last year.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>First Quarter Financial Highlights:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Revenues increased 7% for the first quarter of fiscal 2016 to $1.32
million, compared with $1.24 million reported in the first quarter of fiscal 2015, and decreased 67% from the $4.0 million reported
in the fourth fiscal quarter ended September 30, 2015. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The year-over-year increase in revenue is primarily attributable to
DNA manufacturing for the diagnostic market, two ongoing government contracts and an increase in sales for asset and valuables
marking. The sequential decrease in revenues resulted primarily from the seasonality of the cotton ginning season to the Company&rsquo;s
business.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Total operating expenses were $4.2 million, compared with $5.1 million
in the prior year&rsquo;s quarter, a decrease of approximately $815 thousand or 16%. The decrease in year-over-year total operating
expenses is primarily attributable to a decrease in selling, general and administrative expense partially offset by increases in
research and development expense of $194 thousand and depreciation and amortization expenses of $109 thousand. </FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Net loss for the quarter ended December 31, 2015 was $2.9 million,
or $0.13 per share, compared with a net loss of $7.8 million, or $0.51 per share for the quarter ended December 31, 2014 and a
net loss of $496 thousand, or $0.02 per share for the quarter ended September 30, 2015.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Excluding non-cash expenses, Adjusted EBITDA for the quarter ended
December 31, 2015 was negative $2.2 million compared to a negative Adjusted EBITDA of $1.7 million for the same quarter last year
and a positive Adjusted EBITDA of $213 thousand in the prior fiscal quarter due mainly to a number of non-recurring expenses of
approximately $425,000 incurred during the quarter ended December 31, 2015. See below for information regarding non-GAAP measures.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Cash and cash equivalents as of December 31, 2015 totaled $12.4 million
as compared to $7.3 million at September 30, 2015. The increase in cash balances is due primarily to the registered direct public
offering and concurrent private placement conducted in the quarter that raised gross proceeds of approximately $8.75 million.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Net cash used in operating activities in the fiscal first quarter
of 2016 was $2.7 million.This compares with $2.4 million the corresponding prior-year period. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white"><B>Recent Highlights:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The
                                         Company was featured in a National Public Radio story, aired yesterday, entitled: &ldquo;<I>Cotton
                                         Sheet Conspiracy Brought Down by DNA Testing</I>&rdquo;. Listen at: </FONT><FONT STYLE="color: Blue"><U>http://kvpr.org/post/cotton-sheet-conspiracy-brought-down-dna-testing</U></FONT>.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The Company announces the formation of a Strategic Advisory Board
(SAB) that will provide guidance in specific market verticals. Initially, the SAB will be comprised of two former executives with
decades of experience in the pharmaceutical field who will assist the Company in its entry into the pharmaceutical industry, and
a globally recognized leader of a major energy utility, who will guide the Company&rsquo;s expansion into the protection of critical
infrastructure in power grids and railways.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On December 1, the Company announced that it had successfully completed
a six-month development project funded by existing defense contracts to incorporate its SigNature&reg; DNA technology into various
conductive and non-conductive silicone elastomers. In addition, the project validated the embedding of the Company&rsquo;s SigNature
DNA in elastomers for commercial applications, such as those commonly used in the automotive, medical device and toy industries.
Subsequent project stages aim for a full commercial launch of select DNA-embedded silicone rubber products.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The Company completed DNA marking of plastic master batches used for
the generation of fibers in synthetic textiles. Related projects are underway in plastic colorants and molded products.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The Company expanded its PartnerProtect&trade; channel for print media.
Completion of multiple pilots forms a cumulative experience that will accelerate delivery to an expanding customer base. Categories
include tax stamps for a foreign country, secure labels for United States federal use, inkjet marking and food-grade and pharmaceutical
labels.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The Company announces the expansion of its fiberTyping&reg; business
to a global marketplace. New customers include luxury European men&rsquo;s and women&rsquo;s apparel, top denim lines, outdoor
and performance sportswear and apparel brands, and boutique and large retailers of premium pima products. These customers use fiberTyping
to diagnose if they have a problem in their supply chain, with the opportunity to solve the problem by using SigNature T&reg; tagging
to ensure traceability from point-of-origin to point-of-sale.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The Company received Notice of Allowance from the US Patent Office
for three additional patents, including an additional patent on the genotyping of mature cotton fibers and textiles.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On January 12, 2016, the Company announced that it had signed a Cooperative
Research and Development Agreement (CRADA) with the United States Department of Agriculture (USDA). The Agreement is expected to
enhance Applied DNA&rsquo;s identification of cotton cultivars including the ability to identify key cultivars for specific cotton
growing regions, including those with questionable labor practices. </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">On January 5, 2016, the Company announced a contract with a key distributor
in Europe to provide its metal marking product to one of Europe&rsquo;s leading electricity providers. The contract is for a period
of two years with an option to extend for a third year and is estimated to be valued at between $130,000 and $260,000 per annum.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The Company&rsquo;s Asset Protection Program has advanced westward
from its Long Island headquarters to inclusion in four states, more than 250 communities and more than 100 law enforcement agencies.
Future sales in this vertical will be supported by its relationship with Security Marketing Resources (SMR) of California.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; background-color: white">&nbsp;</P>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; background-color: white"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Preparations are near complete to launch the Company&rsquo;s SMR DNA
Security Initiative for Asset Protection, with line of sight to 500 US security dealers and their 500,000+ commercial and consumer
customers.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">Dr. Hayward concluded, &ldquo;Applied DNA
remains well positioned to benefit from the large and growing demand for supply chain security and anti-counterfeiting solutions
in fiscal 2016. Our pipeline of pilot projects is expected to continue to deepen the validation of our technology and drive much
stronger fundamentals, as evidenced by our success in purifying cotton supply chains. We remain committed to growing the business
in a disciplined, structured way that applies our financial resources to maximize returns. As we move to replicate recent successes
across verticals with near-term drivers of growth, the growing awareness and interest we are receiving from the marketplace serves
to further validate our value proposition and strategy.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Fiscal 2016 First Quarter Conference Call Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The Company will hold a conference call and webcast to discuss its
fiscal 2016 first quarter results on Wednesday, February10, 2016 at 4:30 PM EST.To participate on the conference call, please follow
the instructions below. While every attempt will be made to answer investors&rsquo; questions on the Q&amp;A portion of the call,
due to the large number of expected participants, not all questions may be answered.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>To Participate: </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Reserve your conference call seat now at: http://dpregister.com/10079875.
Conference call dial-in information will be provided upon completion of the registration process.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Live webcast: http://services.choruscall.com/links/apdn160202</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Replay (available 1 hour following the conclusion of the live
call): </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant Toll Free: 877-344-7529</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant Toll: 412-317-0088</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Participant Passcode: 10079875</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Webcast replay: http://services.choruscall.com/links/apdn160202</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">For those investors unable to attend the live call, a copy of the
presentation is expected to be posted by end of business on February 10, 2016 and available under the &ldquo;Investor Information&rdquo;
tab of the company&rsquo;s web site.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Information about Non-GAAP Financial Measures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">As used herein, &ldquo;GAAP&rdquo; refers to accounting principles
generally accepted in the United States of America. To supplement our condensed consolidated financial statements prepared and
presented in accordance with GAAP, this earnings release includes Adjusted EBITDA, which is a non-GAAP financial measure as defined
in Rule 101 of Regulation G promulgated by the Securities and Exchange Commission. Generally, a non-GAAP financial measure is a
numerical measure of a company&rsquo;s historical or future performance, financial position, or cash flows that either excludes
or includes amounts that are not normally excluded or included in the most directly comparable measure calculated and presented
in accordance with GAAP.The presentation of this non-GAAP financial information is not intended to be considered in isolation or
as a substitute for, or superior to, the financial information prepared and presented in accordance with GAAP. We use this non-GAAP
financial measure for internal financial and operational decision making purposes and as a means to evaluate period-to-period comparisons
of the performance and results of operations of our core business. Our management believes that these non-GAAP financial measures
provide meaningful supplemental information regarding the performance of our business by excluding non-cash expenses that may not
be indicative of our recurring operating results. We believe this non-GAAP financial measure is useful to investors as it allows
for greater transparency with respect to key metrics used by management in its financial and operational decision making.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&ldquo;EBITDA&rdquo;- is defined as earnings (loss) before interest
expense, income tax expense and depreciation and amortization expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&ldquo;Adjusted EBITDA&rdquo;- is defined as EBITDA adjusted to
exclude (i) change in fair value of warrant liability, (ii) the loss on conversion of promissory notes, (iii) stock-based compensation
and (iv) other non-cash expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>About Applied DNA Sciences </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><IMG SRC="logo2.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">We make
life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products,
brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud
and diversion.&nbsp;SigNature&reg; DNA describes the platform ingredient that is at the heart of all of our security and authentication
solutions.&nbsp;SigNature DNA is at the core of a family of uncopyable products such as DNAnet&reg;, our anti-theft product, SigNature&reg;
T, targeted toward textiles, and digitalDNA&reg;, providing powerful track and trace. All provide a forensic chain of evidence
and can be used to prosecute perpetrators. We are also engaged in the large-scale production of specific DNA sequences using the
polymerase chain reaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">Applied DNA's common stock is listed on NASDAQ under the symbol
APDN, and its warrants are listed under the symbol APDNW. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>Forward Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">The statements made by APDN&nbsp;in this press release&nbsp;may
be&nbsp;&ldquo;forward-looking&rdquo;&nbsp;in nature&nbsp;within the meaning of the Private Securities Litigation Act of 1995.&nbsp;Forward-looking
statements describe APDN&rsquo;s future plans, projections, strategies and expectations, and are based on assumptions and involve
a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from
those projected due to our short operating history, limited financial resources, limited market acceptance, market competition
and various other factors detailed from time to time in APDN&rsquo;s SEC reports and filings, including our Annual Report on Form
10-K filed on&nbsp;December 14, 2015, which are available at&nbsp;www.sec.gov. APDN undertakes no obligation to update publicly
any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence
of unanticipated events, unless otherwise required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #0070C0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #0070C0"><IMG SRC="logo1.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; color: #0070C0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: #0070C0"><B>Investor contact:</B></FONT>Debbie
Bailey, 631-240-8817, <FONT STYLE="color: #0070C0"><B>debbie.bailey@adnas.com</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in">Sanjay M. Hurry, 212-838-3777, LHA, <FONT STYLE="color: #0070C0"><B>shurry@lhai.com</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: #0070C0"><B>Media contact: </B></FONT>Susan
Forman, Dian Griesel Int&rsquo;l., 212-825-3210,<FONT STYLE="color: #0070C0"><B>sforman@dgicomm.com</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: #0070C0"><B>web:</B></FONT> www.adnas.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="color: #0070C0"><B>twitter: </B></FONT>@APDN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>Financial Tables Follow</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0">&nbsp;&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.</B><BR>
<B>CONDENSED CONSOLIDATED BALANCE SHEETS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">December 31, <BR> 2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">September 30, <BR> 2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">(unaudited)</TD><TD NOWRAP>&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: center">ASSETS</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Current assets:</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="width: 74%; text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Cash and cash equivalents</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">12,382,907</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">7,312,184</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Accounts receivable, net of allowance of $7,140 at December 31, 2015 and September 30, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,923,997</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,929,517</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Prepaid expenses and other current assets</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">187,355</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">293,351</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Total current assets</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,494,259</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,535,052</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Property, plant and equipment, net of accumulated depreciation of $955,765 at December 31, 2015 and $852,867 at September 30, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">561,912</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">572,107</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Other assets:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Long term accounts receivables</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,500,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,500,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-indent: -8.65pt; padding-left: 8.65pt">Deposits</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">58,488</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">62,988</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-indent: -8.65pt; padding-left: 8.65pt">Goodwill</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">285,386</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">285,386</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Intangible assets, net of accumulated amortization of $284,816 and $238,368 at December 31, 2015 and September 30, 2015, respectively</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,584,473</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">1,598,779</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -8.65pt; padding-left: 8.65pt">Total Assets</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">20,484,518</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">15,554,312</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center">LIABILITIES AND STOCKHOLDERS&rsquo; EQUITY</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Current liabilities:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Accounts payable and accrued liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,110,995</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">2,385,006</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Deferred revenue</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">57,526</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">282,050</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Total current liabilities</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,168,521</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,667,056</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Long term accounts payable</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">320,400</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">320,400</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Total liabilities</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,488,921</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,987,456</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Commitments and contingencies</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Stockholders&rsquo; Equity</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of December 31, 2015 and September 30, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Series A Preferred stock, par value $0.001 per share, 10,000,000 shares authorized; -0- issued and outstanding as of December 31, 2015 and September 30, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD>Series B Preferred stock, par value $0.001 per share, 10,000,000 shares authorized; -0- issued and outstanding as of December 31, 2015 and September 30, 2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>Common stock, par value $0.001 per share; 500,000,000 shares authorized at December 31, 2015 and September 30, 2015; 24,072,092 and 21,504,578 shares issued and outstanding as of December 31, 2015 and September 30, 2015, respectively</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,073</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">21,505</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Additional paid in capital</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">232,539,203</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">224,186,760</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Accumulated deficit</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(214,567,679</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(211,641,409</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Total stockholders&rsquo; equity</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">17,995,597</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">12,566,856</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -8.65pt; padding-left: 8.65pt">Total Liabilities and Stockholders&rsquo; Equity</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">20,484,518</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">15,554,312</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.<BR>
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS<BR>
(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="6" NOWRAP STYLE="text-align: center">Three Months Ended December<BR>
 31,</TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="width: 74%; text-indent: -8.65pt; padding-left: 8.65pt">Revenues</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">1,324,114</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">1,241,802</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Operating expenses:</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Selling, general and administrative</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">3,554,362</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,671,490</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Research and development</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">471,934</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">278,288</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Depreciation and amortization</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">218,346</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">109,726</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Total operating expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">4,244,642</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">5,059,504</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">LOSS FROM OPERATIONS</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,920,528</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,817,702</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Other income (expense):</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Interest income (expense), net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,845</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(31,875</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Other (expense) income, net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(8,587</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,685</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Loss on conversion of promissory notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&mdash;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(980,842</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Loss on change in fair value of warrant liability</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">(2,994,540</TD><TD STYLE="padding-bottom: 1pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; text-indent: -8.65pt; padding-left: 8.65pt">Net loss before provision for income taxes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,926,270</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(7,828,644</TD><TD STYLE="text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -8.65pt; padding-left: 8.65pt">Provision for income taxes</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -8.65pt; padding-left: 8.65pt">NET LOSS</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(2,926,270</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(7,828,644</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -8.65pt; padding-left: 8.65pt">Net loss per share-basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.13</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">(0.51</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-indent: -8.65pt; padding-left: 8.65pt">Weighted average shares outstanding-</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; text-indent: -8.65pt; padding-left: 17.3pt">Basic and diluted</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">22,542,176</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">15,456,566</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>APPLIED DNA SCIENCES, INC.<BR>
CALCULATION AND RECONCILIATION OF ADJUSTED EBITDA</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>(Unaudited)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="10" NOWRAP STYLE="font-weight: bold; text-align: center">Three Month Period Ended</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="10" NOWRAP STYLE="font-weight: bold; text-align: center">December 31,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2015</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">2014</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">% Variance</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="width: 61%; text-align: left">Net Loss</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(2,926,270</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">(7,828,644</TD><TD STYLE="width: 1%; text-align: left">)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Interest expense (income), net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(2,845</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31,875</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">218,346</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">109,726</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">(Gain) loss on change in fair value of warrant liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">2,994,540</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Stock based compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">455,110</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,998,524</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Loss on conversion of promissory notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">980,842</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Bad debt expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">10,000</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">2,779</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total non-cash items</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">680,611</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">6,118,286</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Consolidated Adjusted EBITDA (loss)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(2,245,659</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">(1,710,358</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">)</TD><TD STYLE="font-weight: bold; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right">31</TD><TD STYLE="padding-bottom: 2.5pt; font-weight: bold; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="10" NOWRAP STYLE="font-weight: bold; text-align: center">Three Month Period Ended</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="10" NOWRAP STYLE="font-weight: bold; text-align: center">September 30,</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD NOWRAP STYLE="width: 61%; padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="width: 1%; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 1%; border-bottom: Black 1pt solid; font-weight: bold; text-align: left">&nbsp;</TD><TD NOWRAP STYLE="width: 10%; border-bottom: Black 1pt solid; font-weight: bold; text-align: center">2015</TD><TD NOWRAP STYLE="width: 1%; padding-bottom: 1pt; font-weight: bold; text-align: left">&nbsp;</TD><TD NOWRAP STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD NOWRAP STYLE="width: 10%; padding-bottom: 1pt; text-align: right"></TD><TD NOWRAP STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD NOWRAP STYLE="width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD NOWRAP STYLE="width: 10%; padding-bottom: 1pt; text-align: right"></TD><TD NOWRAP STYLE="width: 1%; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Net Loss</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">(496,034</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Interest expense (income), net</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">(3,340</TD><TD STYLE="text-align: left">)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Depreciation and amortization</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">136,496</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">(Gain) loss on change in fair value of warrant liability</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left">Stock based compensation expense</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">562,933</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Loss on conversion of promissory notes</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Bad debt expense</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">13,246</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Total non-cash items</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">709,335</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: Azure">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Consolidated Adjusted EBITDA (loss)</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">213,301</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;&nbsp;&nbsp;</B></P>


<!-- Field: Page; Sequence: 7; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Gainsboro 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *0$+ P$1  (1 0,1 ?_$ +,  0 " @,! 0$
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M3?719[:,E5TUE>23Z1AF;1(R'PG9'YUFT6LX*19!R40;\BNKI\6JMGMAXO\
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M?]O[O(O9F_,=T92/?91I-P1AW%6:,F43-PSB$AT6,<S?'C9)E.J@M\E994!
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M:L;-' H_A'JA2D&4K$\U.UGJO+@4@ #N/<MG'0.G?V]0X4@D=%Y>MEOVNKN
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#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo2.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ M "T P$1  (1 0,1 ?_$ -    $$ @,! 0
M       &!P@)!0H! P0""P$!  (" P$!              8'!0@! P0) A
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M4]$Q;AX)E$ ,8/'SU+T9-HVM9T6\[@=3YD]?U"M'\['W'O?W>R-AS<B2+C&
M\@"*;:8HF"$JO5?<E?Q<CH#\J:J)SQ>F<DDZDG;:3CQ5*+I@9F@W+V1-\_I5
M4 (JBH0NXE$1,&_GK%0[[G)*'E(:._46MT^5JN3>_MT[>YVT/B;3#+B[D$/M
MS>XSG5;I[BM<,I/U6 Z>%J56?:W%G;0=TCT$TQF1(V?E*F0A70*-@=LG2I *
M!?4 GN4QO,WA\0UZ]^QX[1YL/I+]#\[B]_Q\C4,^W#E&ZC*W'@6ZN9$P@7BN
M2=&F3VY$!/[%[,H\O*K6O:\]X>V<>9"N8(Y+34G;\#.EV\36[Q(J+R=HQ(98
MX(MTWKQ94[N;H1#G*!TSB=Q'$^=(3) 9/6G7>;L'A\GBEY+P^-(.2 %I(%LL
M>3;J2H'1)OAX*YZ&QZU]-^T_>K-X[+'Q[E,CS["Q"I*;L^/?PU&]VB^(ZE/$
M=.E;3_))W9KEQ\EGN(I*:F&=F)5G$A+8R=I/+A)8MDY>-4NKS&;QJMVG5H>T
MQ5R,<=(_<,8^Z(]WMZTIXLF+@<E1-Z1(Y(3( LX(C6=5;VA."+A!+IU@CP'J
MZ7K;CDKY.;QYWVAW=)0A+0&\A@9@9#"0>KF.^BQ_#K:HI88X]N)U[1&&*4)W
M&/$6F922RNPQODBBV"K97:9%JI@78M:8YGQ&00Q9:)AZ,D[6D"_5#N45T$Q]
M,Y-TS'?N3"!,F7>3'E\TGQ/RYGAE23',,G1C*$Z'(C4:%">@*58C4HJ);-QU
MLB3'3:1)B\0@RO?$,T3I.)D\!&6Z^P['6Q?UW!4>EJM(U4=ZM2D99D5(ERWN
M#%/J5C41;3R)0'J?5PR@*N3](!\[J&/NY1'SZ 5(']YMKFE+!)5-=)-9%0BJ
M*R9%4E4S 8BB:A0.10A@W Q#E$! 0\!#2E=FE*-*4B8G_;MEE)TX=3&#%>N0
MGQ*=R4Y#V"1*&VPF.Z3(U((>16Y]OQCI2D9F2#S>^:P<W@VZ5:#GZ\Y=.9"G
M7N"-(TS(3%=-(OT>5FHWILM3=MQ2$S5\R[Q4U#CWFZQ/E#.['D;!'))!R"":
M3&E  DB?3+"1?U*K>B0']I&M<?2RFL)O,&^2)'/L4\4>1&23'*MXY0?V68>M
M"/V66_7Q4BD%CSE-7INT-\89;K4O@;,:QC),J3>W#4T+<3)B8%'F+[ZUZ*S?
MV!NC<$VYTI%,!_-:IB ZR.Y<0RL?$.[;-*FX[&.IEB!U1?*>$_Q(3\R"A\G-
M>#;N58T^4-KW>)\#>3T$<I&F3YP2CT2CY AQYJ*55U/@WC3"Y@Y&3[*&H;)6
M$)9<HV1H*C-.="N-G ,G;F,(NG&O;([]1Z9-8B(/'IS))'.?I(!?)MZ<AY9D
MX/%\5I,F;W/;QXSU*:R+@-;4$'U$$Z5 ) '6O5G'8>+X^9R3(5,>+V]<[CH&
MT V)6]BY\ ;:F) )/2M"+G7S4R%SBS?+9-M:KR+IT6H[B<5T(ZPF9TNI"L H
M%43(/97L4P!"KR+G;J.J;ME$$DR%#Z<]LNW>U]M^.)M.&%?<I &R9K=99/EY
MB-/I0? 7/4FOGEW!YUN//M^?<\O4F A*X\5^D<=^E_+6WBY^/3P%0OU8E06C
M2E&E*-*4:5S4T>(/ K/G-]>]-\&ITPZF.R0A[$%NLAH#8+ +[Z>+#H8OA=;?
M3E.OP*!?#SWU7?/NYW&>W QCR+\Q_P WKT>T@?Z+:M7J%OJ%JG'"NWG(>?'(
M78?8OC:=?N.5^N]K6!OX&]1MRIC:R8=R1>L4W(& 6O'MEDZG8OI+OU\8$M%+
M=EV#!]VT@=M@/^$_07J#X:EVQ;SA\BV;&WS;]?Y'+A61-0TMI:]M0N;'XB]1
M?=MLRMCW7(VC-T_G,:4H^DW74O0V/2XI^#(_S,PH@DRV6FZ^DENW*.Z@O8@A
MBBGT^>[V/\2?:8=M6&!_,]E"K_?H!T^:_P#:*T629NT_?N27.NFP[D[>L]%]
MK(((:_\ X<O1O@*CE3ZG(W&=:PS%(Y2F4*>0<"0W;8,TS!ZA58WCTF  $I2C
ML)CB ?;J.X6))F3B%/CZC\!\ZVEYUS3:^#\<FWS<'4OH(A0$:I9&'H"_$7L2
M1T"W-/5G^?8E^A4J/.4WT<A';X"F WIQ!L#9BU/MY*@@ G,'F&X?;K,[]D1@
M)A1F^CJ?EY ?C;QJA?MJXUN#-N//=R4K^=)CBN"-=WURR#^SJLJGP)!J-@^.
MX?#[/,/_ #:C?]=;6UL:^R-[DCS'%HA.'&:IXZV.K:^])A:RRSDH%I%I>'.H
M6C.GJY@$E;L;@VS ##TM'INV78BH=.I'W&=HTW/$D[@<>B W*%;Y<:#^]C'3
MW@!^V@^NWBO7Q%;-]A^Z#[;EQ\)WV2^W3-;&=O\ =.;_ ,(D_L.?H_=;IX&M
MJ'+5WN%&KC9W0L8SV5[9+2K6%AZ[$R49!1S5PZ364^L6NQRRH-J_66)41%PY
M(DZ6W$I$T5#F -:6;+M^#N&64W'+CP\-$+,[*SL0+>F-%ZO(;^D74>98"MN-
MWSLS!Q@V!BR9>6[A512J@$_M.[&RH+=38GR )J!%LN><<:9.QU,W+.3#(N>+
M78X" ;<1<60HFQY$8[LD_'(VRQ.2!W;D5Y4X3N.PM<\L@P$6YD4FB?>Z-6-A
MX&P;MM.3!@;>V+QZ")W.Y9#_ ,9ID1C&@_W5I&LOY>$,_J#%S:]5_E9N^[9N
MF--FYRY._32*@V^!?X*Q.PUN?]Y>-?5[\I"]+!!>K2#%*<HE,4#%, E,4P )
M3%$-A 0'<! 0U48JU*154ZHEU+5%7<"1!TWL&)Q_O*[(F5,U13$1$QPB7::K
M8?\ -(1/?;J#2E+;2E)^TRJD- 23]  ,\*AZ>.3'805DWARLXY(2[@)BG>KD
MWV\>G?2E>F!B4X.&C8E(PJ R:II**F'<[AP/YCITH/Q4=.3G4-]IC#K@TJ+U
MQY;QE7MUF@(?"N>,CURBRGT&[Y!QQ265DK=>L!&360>PZ;'ZXTM,^XB&CY$S
MTT:P=$;F/T;F. E":8'"Y<S"BR)\_;L7*R$UQ0SRE)'2Y4-?08T#$'3K=;VO
MT'6HAF\OBQ,R6"'!S\G&@;1++#$'1'L"5MJ#MI!&K0IM?S-.Q7)_#').CQ%F
MA_TMDVF_5TG\>>0BTGOT>SUUZ4X%<QDNT)(URT0$BB '272;O&J@;&*7?QP^
M7B[[Q;/DP\CWL3.T$-9B-4;CR939XW'@02K#XUEL>?9.38*94/M96'KNMQ?2
MZ'S#"Z.I\00&!K5]]_SFBXMU]A.&U'E#%J]!-&W#+JS1<>W+W-XW,XK56<]H
MX@HVK<:N5XLF;P%TY(!@W2#6Y7VO]O5P]ND[@;DE\O(U18H(^F(&TD@OX%V&
M@']T&WC6J7W%<Y;,STX1M[_\K!:3((/1I"+I&?B$'J(_>(OX551[>7"Q'G=F
M^:PZMD1;&9(B@RMV+/H5U*SJ.#1LI$QH1HL%I.)(F"WU3K%7NB)>C;I'?5V=
MV.XC]L^/1;ZF*N89,I8M!<QVNK-J!"M^[:UO/Y54';;@B]P=]DV5LDXH3':7
M6$UW(95M:Z_O7O>K7FO]/H[K;;.=GR5G:20IF/8::>XV4@:Q%LYZ]FAJE]=<
MRTZB]DI%E 1?U4IV:2"1EEUBHG4$R8"0!HZ3[J/S;;=B;5MB?G\F1!/KD8I%
MJDT!8R "YTV8EK $@6-C5PI]N!Q4S\K=-P<86.C&'0BAY=*:]37)"K>Z@"Y-
MK].E1DX.>SXYY$8-+R?Y!YE:\?<*/&K^3@US,HXTS*0$:Y.S7M,K*V%XRA*Y
M .'22A&QC@LLN!>K8I3$ZIEW([^KQ7D1X=Q7 .Z<@4JKW+:%=@#[:I&"\C@$
M:O #PZV-13@795N2;#_BODF<-NV-@63HNID!L79G(5$)!T^)/CTN*57+KV:(
MG%_'R1Y1<5\]MN0F+Z_%*6"P,E&T,L^4K+5;T\C8*O8*RZ<1,XC#& QW;8Z:
M2J:1#F QA(8NO%P3[@\C>>4IPWFNVG:]VEDT(UW $A^E)(Y &0OX*P)%R.G6
MO7S/LA#M7&VY7Q'<1N.UQIK<'23H!ZO&Z$JP7]I2 ;7^%,_[=OM06#FQ2;'F
MF]Y.;X:P=6Y-_$)SZ<:TDIRPNX5J1W/.69I-XQB(6"A$E"@N\<&. G$P%)L0
MQ@S_ '9[X8_;S<8N.[7AG/Y)*BL5+%4C#FR Z06=V\D6W2W7J!6$[:=G\CG6
M!)OVXY8PMAC8KJ"@LY47<BY"JJ^;$G\.E3,M7L3XHR)BJQ9$X:\O&.8Y.OIR
M1$8N00K$W79R6B6QG#FO$LM/?":$EW!0*5$%D%2=1RB;8@]6J]P?N8WW:M[B
MVOGVQ'!QY--V7W$D16-@^B4>M1XFQ!L#;K4YS/M^V;<MHDW+A.\C,EC#64A&
M1F47*:XSZ6/E<'J1Y4O/Z;UNNSL'+AFZ1.W=M"8T:.FZH;*MW+5S;&[A!0/@
M=%=,Q1^\-8_[M722#8I(R"C#(((\""(R#^D5D/MC1XY]XC<6=?9!'P(+@_TU
M1KS^_P"^]RL_[<+Q_P!(CK8[M1_TUV3_ ./B_JJ@>XO_ .^;O_ZZ3^ND9@!I
M;49EP_8M^BK.$Q2EEW8G20641 QD#L!$-EG:!Q^80^4""(&'RU</'TREG,B"
MV*1ZB? _A\Q6EGW*9O#)MCBV[/EU<PB?5CI& SJK6UB;]U''@#ZBP! \:=?(
M$N7&];>2E-@69%)Z1.J]F&X$4;,W+H-P>*E*)A7%4VX)  @B0_P\=AR^?+_+
M<9IL.,7=NK#R)\_G\O*J8[:[,>ZG*H-GYUN,[0[=C@18SDAY$C\8U)L%TBVO
MIK9?PZ0G<.'#Q==TZ64<NG"QUW#A8XJ*K*J")CJ*&'Q$QC#^P-0AG:1R[W+G
MK>M_\3%QL'&CP\*-8L2) J(HLJJ!8 #\*Z=A^S7YN*]%?22JR"J2[=95LX05
M27;.6ZADG#9PBH55!PW63$ITET52%.0Q1 2F !#7#*KJ4<!D8$$'J"#T((\P
M1TKD,R,&0D.#<$=""/ @_$5OL^U;R_/S8XCM M$T[;Y:QVV'&.37L<Z*UFE7
MB<9VH&\LE@(<S5U88G9P542FZ7R*WA\NOF-WIX&.WO.73$C4[)E'\QCAA=0I
M:[0GX^VWIM^Z5^-?0WM)S3_'7#E.4[#>,8>Q.0;-?3Z9!\"R];_O U-C'N)L
M+<:ZQ+O(-O$U9JY.:3NN0[E.>LLMD?&V%>9N]^LKL\G*N55 ZMW#CLI".R1"
M%V+JNMRWG?N59:1Y!>9AZ8H8ELB#R6*&,:5'^:MSYDFIWMVT;)QG&>2 )$IZ
MR32-=W/FTDKF['\38>0%+2A99Q?E-"0<8UR'2K\A$+)MY16GV6'L1(Y98#F1
M(]&*=NO3"N"9A3$^P' H].^PZ\.X;/NVT,J[KC3XS.+J)$9+@>-M0%[>?PKW
M8&[;7NH9MLR(<A4-F]MU>Q^>DFU>FUA]-DJU9RF$B;"1"&E1#;H-$6$Z3(#J
M^.XD:RQ6JGV%+U#K&UD*7&E*1-D*$A8*;#" F2!^]L;L@#M^3 -R%:"?X]/U
M:2;CM\>D?LTI2VTI4)ICC/E2@VF\9 XT9SD:O+9 L#JVVO&V8HY?)F)YFR.D
M4$%7\6*3N(NM&5<(-DTU!8/EFYBIEW;CTAJ>P<KV?<<+'VSE6WK-#C1B..?&
M809*H"39KAHI@"21K0'J?54'FXQNVWY>1N/&<]HILF0R/#D S8[.18E;%9(K
M@ '2Q'3Z::>AY$R-QDH/*?*/)3&B%7LS&.F\VVF^4R4B'N$K>^BH./K4) TQ
M(736VQ$NY;Q+0K@DJR*Y<K*G5,N?<I0S.X;5MG+=TV?9^*99FQ7=,2.*56&5
M&&<NSR^,;*"S6]MM*@!0HK$8.Y[EQ;;MVW;DV*(LE4?)>6-E.-(54(J1]1(K
M'2MPZZF))N:T-;]>K'D^\7'(]N>+2%HOEFFK=.NUS"<ZLE/2"\@N7J-OLDAW
MNVF4/ J9"@'@&OISM.UXFR;7C[/@J%P\6%(D _=10/UGQ)^)KYZ;EN&5NVX3
M[IF,6RLB5I&/S8D_T> JZG^GM_[[=R_[!K3_ -9ZIK7?[JO^GV+_ /)I_P .
M2KU^V[_]ZG_^/?\ XB4D/?2S1E25YOWK'JM\M;2D4&ET]C6*K%3LG$PC0)NN
MI3$RZ781[IN@^?2+MX8%%5@.84BE)X%#;7M^VOCFQQ]NH-W.+ ^YY.3*7D=%
M=C[;Z4 + V"@= +=;GQKQ]_]]WB7G<^V_F)EP,>",)&K,JC4NIB0I%RQ/4F_
M3IX5L)Y^PSA&\^USBW$F7<TM>.F)G.-<!HR60#DCO1(':Q5?D640NE(JMV2A
M)^2(!3 8WS&'?Q'6J_%N0<AVWO%E[[L6WMNF^+EYA6#U7-VD!;TW/H7KX>%;
M(<BV/8L_M1B[-O.<-MV=L;%#3=+= C!?5T.MO&H[<><F>W9Q/X9Y-XNP?.G%
M^5HN?B<JNXY:=FH6+?"I>:^X0/ -(Z.6<('1%]U&3Z1ZCJ+#X;^<LY7LW=7G
M'/\ %YED\;S,*>-\8,$1V7^"X.LLUC>WC\A4:XYNO;;A_",KBD&_XN7#(DY7
M6R@_Q4(T@"XM?P^9JL+VZL'^X_R,XLV/&-!S74\%<*W*%PK<O+W2K0DBM8V<
MN=Q^N"5M0L<2<69I"=0J[U=^U;I&ZB$./2;:XN['(^TW%.:Q;ON6W3[EW#4Q
M2!(I758V4#VO<%RM_ A C,>A(ZBJI[:[!W-Y+Q.7:]NSX=OX.PE1FEC4EPQ/
MN:.FJWC=BRJ/(U>;[4. ^,W&_&>6<<<>L_,>0TNA<XU]EFUPRK T#%64T 5K
M%P44C$'=Q2";>-;"8_;=.53"8!4, [%#7#O9RGE_+]YPMWY3MC;7"<<C&C8,
M&:/7=G8O9C=CYJH^%7[VBX[Q;B^TY>U\<W!=QE$P.1(MM"OIL%4+=1Z1Y$GX
MFJ]/8#_^LW/L/( O<2   ;  !<,@   &^VVK2^Y@WX[Q8_\ ],_\*"JW^WC_
M /W>1>7_ #(_XDM4I\J:&%XY_<K4GG66%B\WW5U*B3<IEP-)B5!BF</PF<F
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M:JB5(JSM5%,R@E 1Z0$1V 1VV =:U?=+#+-V_P 5(49W_F2=%!)_NY/A5_\
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M:T:W^'?OM^YID9.S*TO%MS@D$:DV7U V0GK:2!C=?-E_&F_Y!V%%[-15::&
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M":1*JD"P<$?&]ZENDDB@DF@@DFBB@F1%%%(A4TD4DR@1-)-,@ 1--,@ !2@
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M;:;,1U])ZK\;>7AY5XO4)_J?JW_^[?I_(?[S^5/;V\OM\=8FLK2@K3Q-.Y9
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MH@P*F4^)5%(1>K-:MC]I[0=O^,YF/M_,<F7/WN6!YV2(E,>&&,7>20@@B,>
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M2/=G>-\X)LLN[\1PD,F5*3D9'5C ="H'$?@-0 &KZ00-0-ZTRHC-V8(+*_\
M/6(R9<F>8QFE["KDI.;=FM;J7=&$SIP\D5#G%Z@Z >A1NH!FQTOD$G1L&OH1
M/QKC^5L7^&9\/';C_MA!!H'MA1X6'D1XAAZK];WK1V#D&^8^[_X@ARYQO6O7
M[VHZRQ\;GS!\+'H1TM:M@_CA[QV$LPI4BK<[*BM1[S5[Y6+S'9_Q=&$:P]BL
M%9CGE?CG.1X-DDYDFA75?E7+%V9$CEHHU5$I2(  ;:J<N^WWD>P-D9W;6?\
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MO,E2#W%'&2I6N2L&0.,=/@\?H*'E9R(%!Q7PJCEQ7?4V,(Q=&,@I>72;MA6
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M7-ZDS*O<?VR4BI9&DL\A3]=5.> F/TO'OCP3E<0$ZD;9YQN@UB3'%,HG.@X
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>/3X=/3T^'3MI2OK2E&E*-*4:4HTI1I2C2E&E*__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
